U.S. market Open. Closes in 7 minutes

QNRX | Quoin Pharmaceuticals, Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/A-280.00KN/A-280.00KN/A
Cost of Revenue103.44K103.64K104.11K104.77K227.06K125.72K104.22K89.13K18.27K
Gross Profit-103.44K-103.64K-104.11K-104.77K-227.06K-405.72K-104.22K-369.13K-18.27K
Operating Expenses9.38M9.26M6.06M1.67M1.56M16.22M10.10M16.22M2.58M
Selling, General & Admin6.07M6.58M4.50M1.43M1.51M7.97M4.20M7.97M1.06M
Research & Development3.31M2.67M1.56M244.16K45.65K8.26M5.89M8.26M1.52M
Other Operating ExpensesN/A417.31K-14.03M-378.33KN/AN/AN/AN/AN/A
Operating Income-9.38M-8.85M-20.37M-2.05M-1.56M15.32M10.17M15.32M-2.60M
Other Expenses / Income714.32K-123.79K-1.09M-425.35KN/A2.54M-1.06M237.07K-19.30K
Before Tax Income-8.66M-9.38M-21.46M-2.10M-1.56M15.32M10.17M15.32M-2.62M
Income Tax Expenses22.38K-104.04K-12.94M-331.31K1.55M-161.14K-1.17M147.94K-1.00
Net Income-8.69M-9.28M-8.52M-1.76M-1.56M15.32M10.17M15.32M-2.62M
Interest ExpensesN/A714.08K1.09M47.02K412.29KN/AN/AN/AN/A
Basic Shares Outstanding900.92K403.88K26.41K20.02K3.54K2.16K1.87K1.52K1.24K
Diluted Shares Outstanding901.10K403.88K26.41K20.02K3.54K2.16K1.87K1.52K1.24K
EBITDA-9.27M-8.74M-21.37M-2.01M-1.54M-5.47M-7.80M-3.91M-2.60M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%1,953.07%0.00%1,394.93%0.00%
EBIT-8.66M-8.67M-20.37M-2.05M402.27K15.16M9.01M15.46M-2.62M
EBIT Margin0.00%0.00%0.00%0.00%0.00%-5,412.81%0.00%-5,523.19%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙